Literature DB >> 1129271

Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).

S I Wasserman, D Whitmer, E J Geotzl, K F Austen.   

Abstract

Purified human eosinophils demonstrate diminished chemotactic responsiveness (deactivation) after incubation with the eosinophil chemotactic factor of anaphylaxis (ECF-A). The deactivation is rapid and selective in that ECF-A deactivated human eosinophils more markedly than neutrophilic or mononuclear leukocytes. The eosinophil can also be deactivated by C5a which is eosinophilotactic, and there is cross deactivation between C5a and ECF-A. Deactivation may be an important physiologic control mechanism enabling the eosinophil to remain at sites of ECF-A release in order to manifest its regulatory functions in immediate hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1129271     DOI: 10.3181/00379727-148-38527

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  21 in total

Review 1.  Pharmacological studies of pulmonary anaphylaxis in vitro: a review.

Authors:  P O Ogunbiyi; P Eyre
Journal:  Agents Actions       Date:  1985-12

2.  Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.

Authors:  S I Wasserman; N A Soter; D M Center; K F Austen
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 3.  FPL 55712 -- an antagonist of slow reacting substance of anaphylaxis (SRS-A): a review.

Authors:  N Chand
Journal:  Agents Actions       Date:  1979-06

4.  Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.

Authors:  W König; N Frickhofen; H Tesch
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

5.  Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.

Authors:  P Gosset; L Prin; M Capron; C Auriault; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

6.  Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.

Authors:  E J Goetzl; J M Woods; R R Gorman
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

7.  The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria.

Authors:  S I Wasserman; K F Austen; N A Soter
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

8.  Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.

Authors:  E J Goetzl; A H Tashjian; R H Rubin; K F Austen
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

9.  Modulating influence of chemotactic factor-induced cell adhesiveness on granulocyte function.

Authors:  J Fehr; C Dahinden
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

10.  Chemotactic deactivation of human neutrophils: evidence for nonspecific and specific components.

Authors:  R D Nelson; R T McCormack; V D Fiegel; R L Simmons
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.